Schistosoma mansoni: Developmental arrest of miracidia treated with histone deacetylase inhibitors - Archive ouverte HAL Access content directly
Journal Articles Experimental Parasitology Year : 2009

Schistosoma mansoni: Developmental arrest of miracidia treated with histone deacetylase inhibitors

Abstract

In the present study, we examined the effect of the histone deacetylase (HDAC) inhibitors trichostatin A (TSA), valproic acid (VA) and sodium-butyrate on the metamorphosis of larvae of the human blood-fluke Schistosoma mansoni from the free-swimming miracidia into the intramolluskal sporocyst. We show that HDAC inhibitors block transformation in concentration dependant manner. TSA reversibly blocks this developmental process: only 13 ± 11% of TSA treated miracidia transform into sporocysts in-vitro, compared to 92 ± 3% in the mock-treated control. Other enzyme inhibitors such as cycloheximide or hydroxyurea had no effect on metamorphosis. For treatment of up to 4 h, the effect of TSA was completely reversible. Our data indicates that HDAC activity is necessary for the transformation of S. mansoni miracidia during infection of the snail host
Fichier principal
Vignette du fichier
Azzi-2009-ExpPara-Schistosoma-manuscrit.pdf (323.58 Ko) Télécharger le fichier
Origin : Files produced by the author(s)
Loading...

Dates and versions

halsde-00371695 , version 1 (01-04-2019)

Identifiers

Cite

A. Azzi, C. Cosseau, Christoph Grunau. Schistosoma mansoni: Developmental arrest of miracidia treated with histone deacetylase inhibitors. Experimental Parasitology, 2009, 121, pp.288-291. ⟨10.1016/j.exppara.2008.11.010⟩. ⟨halsde-00371695⟩
72 View
114 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More